Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000882183 | SCV001025410 | benign | Developmental and epileptic encephalopathy, 36 | 2024-01-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001556965 | SCV001778644 | likely benign | not provided | 2021-05-21 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000882183 | SCV002524926 | benign | Developmental and epileptic encephalopathy, 36 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000882183 | SCV002808041 | likely benign | Developmental and epileptic encephalopathy, 36 | 2021-11-19 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003920566 | SCV004732982 | likely benign | ALG13-related disorder | 2023-03-08 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |